Natco Pharma announced today that it has launched Valsartan-Sacubitril tablet at an affordable price, under its brand VALSAC. Valsartan-Sacubitril is a combination drug used for certain types of heart failure, and works by relaxing blood vessels, making it easier for the heart to pump blood to the body.

NATCO has launched VALSAC in 50 mg & 100 mg strengths at an MRP of Rs 45.0 and Rs 55.0, per tablet, respectively.

Shares of the company declined Rs 8.5, or 1.25%, to trade at Rs 670.05. The total volume of shares traded was 2,059 at the BSE (10.20 a.m., Monday).